Demand Imbalance Arbitrage

The Only Trading Method You Need

Forecast Future Price Action

Investing in Growth Stocks: WMT, VRTX, PARA, META, and AMZN


In the fiscal third quarter ending on October 31, 2022, WMT’s total revenue saw a year-over-year increase of 8.7%, amounting to $152.81 billion. Its adjusted EPS came in at $1.50, representing a 3.4% year-over-year rise, while its total assets increased by 1.1% from the prior-year value to $247.66 billion.[0] Analysts expect WMT’s revenue to increase 3.9% year-over-year to $145.72 billion for the fiscal first quarter ending April 2023, with an EPS of $1.38, up 6.5% year-over-year.

Vertex Pharmaceuticals (NASDAQ: VRTX) is a stock ripe for the picking. For the past 10 years, the company has grown at an annualized adjusted earnings growth rate of roughly 10%, compared to most electric utilities which are growing by a low single-digit percentage.[1] It expects to develop between 32.7 GW and 41.8 GW of combined wind, solar, energy storage, and wind repowering projects from 2023 through 2026.[1] Vertex also has its sights set on big markets beyond its current Cystic Fibrosis (CF) indications, and could win regulatory approvals as soon as late 2023 for exa-cel in treating sickle cell disease and transfusion-dependent beta-thalassemia.[2]

Another no-brainer stock for investors with $200 ready to invest is Paramount Global (NASDAQ: PARA).[1] This media stock has seen a sizable rebound lately, and is a great buy for those looking for a dependable growth stock with the potential to deliver double-digit returns in the coming decade.[3]

Finally, social media stock Meta Platforms (NASDAQ: META), formerly known as Facebook, is a great buy.[4] With a market cap of only $2 billion and potential to deliver megablockbuster sales, this stock is a no-brainer.

When it comes to growth stocks, one should not underestimate Amazon (AMZN 0.16%). Famous investor Bill Miller recently called Amazon “one of the easiest names in the market right now,” and for good reason.[2] With its long-term prospects looking brighter than ever, the company is on track to launch new products for five disease areas within the next five years, each representing a multibillion-dollar market opportunity.[2]

0. “WMT: 2 No-Brainer Stocks to Buy and Hold Forever”, 15 Feb. 2023,

1. “3 No-Brainer Stocks to Buy With $200 Right Now” msnNOW, 14 Feb. 2023,

2. “The Best Stocks To Invest $5,000 in Right Now” The Motley Fool, 12 Feb. 2023,

3. “Don’t Wait for a Market Bottom: These 2 Stocks Are on Sale” Yahoo Canada Finance, 16 Feb. 2023,

4. “2 “Strong Buy” Stocks Set to Outpace the Market” TipRanks, 15 Feb. 2023,

Forecast Future Price Action
This div height required for enabling the sticky sidebar
Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views :